Truveta will provide the CDC with access to anonymized electronic health record (EHR) data from over 100 million patients, offering a comprehensive and timely snapshot of real-world healthcare experiences. This unprecedented access will equip CDC researchers with novel insights into:
- SARS-CoV-2 variants: Understanding the spread and impact of new variants is crucial for informing public health measures and vaccine strategies.
- Vaccinations and testing: Truveta’s data can reveal the effectiveness of vaccination and testing programs, helping optimize resource allocation and improve public health outcomes.
- Re-infection and long-term effects: Studying re-infection patterns and long-term health impacts of COVID-19 will be vital for developing effective treatment strategies and managing long-term consequences.
